Characterization of FosL1, a Plasmid-Encoded Fosfomycin Resistance Protein Identified in Escherichia coli.

Détails

ID Serval
serval:BIB_5209F44D41B1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Characterization of FosL1, a Plasmid-Encoded Fosfomycin Resistance Protein Identified in Escherichia coli.
Périodique
Antimicrobial agents and chemotherapy
Auteur⸱e⸱s
Kieffer N., Poirel L., Descombes M.C., Nordmann P.
ISSN
1098-6596 (Electronic)
ISSN-L
0066-4804
Statut éditorial
Publié
Date de publication
24/03/2020
Peer-reviewed
Oui
Volume
64
Numéro
4
Pages
e02042-19
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Fosfomycin is gaining renewed interest for treating urinary tract infections. Monitoring fosfomycin resistance is therefore important in order to detect the emergence of novel resistance mechanisms. Here, we used the Rapid Fosfomycin NP test to screen a collection of extended-spectrum-β-lactamase-producing Escherichia coli isolates from Switzerland and found a fosfomycin-resistant isolate in which a novel plasmid-mediated fosfomycin resistance gene, named fosL1, was identified. The FosL1 protein is a putative glutathione S-transferase enzyme conferring high-level resistance to fosfomycin and sharing between 57% to 63% amino acid identity with other FosA-like family members. Genetic analyses showed that the fosL1 gene was embedded in a mobile insertion cassette and had likely been acquired by transposition through a Tn7-related mechanism. In silico analysis over GenBank databases identified the FosL1-encoding gene in addition to another variant (fosL1 and fosL2, respectively) in two Salmonella enterica isolates from the United States. Our study further highlights the necessity of monitoring fosfomycin resistance in Enterobacteriaceae to identify the emergence of novel mechanisms of resistance.
Mots-clé
Anti-Bacterial Agents/pharmacology, DNA Transposable Elements/genetics, Drug Resistance, Bacterial/genetics, Escherichia coli/drug effects, Escherichia coli/genetics, Escherichia coli/isolation & purification, Fosfomycin/pharmacology, Humans, Microbial Sensitivity Tests, Plasmids/genetics, Proto-Oncogene Proteins c-fos/genetics, Salmonella enterica/drug effects, Salmonella enterica/genetics, Salmonella enterica/isolation & purification, Switzerland, beta-Lactamases/genetics, beta-Lactamases/metabolism, Escherichia coli, FosL1, fosfomycin, plasmid
Pubmed
Web of science
Open Access
Oui
Création de la notice
17/01/2020 17:16
Dernière modification de la notice
17/02/2024 8:12
Données d'usage